These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

55 related articles for article (PubMed ID: 1833956)

  • 1. Clinical-instrumental evaluation of the effects of mesoglycan sulphate in chronic vascular encephalopathy.
    Orlandi G; Viapiano F; Massetani R; Ferrari M; Murri L
    Acta Neurol (Napoli); 1991 Jun; 13(3):255-60. PubMed ID: 1833956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of mesoglycan in patients with previous deep venous thrombosis and chronic venous insufficiency.
    Andreozzi GM
    Minerva Cardioangiol; 2007 Dec; 55(6):741-53. PubMed ID: 18091643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Controlled multicenter study on the therapeutic effectiveness of mesoglycan in patients with cerebrovascular disease].
    Abate G; Berenga A; Caione F; Capodaglio M; Cuzzupoli M; Guido A; Forestiero G; Guizzardi G; Mancini G; Viscanti G
    Minerva Med; 1991 Mar; 82(3):101-5. PubMed ID: 1826046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness of mesoglycan therapy in patients with ischemia of the lower limbs. Preliminary results of a new therapeutic protocol].
    Raso AM; Maggio D; Trogolo M; Rispoli P; Sandrone N; Pezzuto D; Bellan A; Melloni CD
    Minerva Cardioangiol; 1997; 45(7-8):383-92. PubMed ID: 9463174
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Mesoglycan in acute focal cerebral ischemia].
    Cazzato G; Zorzon M; Masé G; Antonutti L; Iona LG
    Riv Neurol; 1989; 59(3):121-6. PubMed ID: 2531910
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of mesoglycan in patients with cerebrovascular disease: a psychometric evaluation.
    Ambrosio LA; Marchese G; Filippo A; Romano E; Musacchio R
    J Int Med Res; 1993; 21(3):138-46. PubMed ID: 8299857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological treatment of mechanical edema: a randomized controlled trial about the effects of mesoglycan.
    Viliani T; Scarselli M; Pieri A; Gatti M; Santini M; Pasquetti P
    Eur J Phys Rehabil Med; 2009 Mar; 45(1):21-9. PubMed ID: 19270639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Instrumental evaluation of the effects of mesoglycan in venous disease patients. A prospective randomized double-blind study].
    de Donato G; Sangiuolo P
    Minerva Med; 1986 Oct; 77(41):1927-31. PubMed ID: 2946988
    [No Abstract]   [Full Text] [Related]  

  • 9. [Mesoglycan in acute and chronic venous insufficiency of the legs].
    Sangrigoli V; Carrà G; Lazzara N; Micale F; Puleo MG; Bonaccorsi R
    Clin Ter; 1989 May; 129(3):207-9. PubMed ID: 2527115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effectiveness of mesoglycan topical treatment of leg ulcers in subjects with chronic venous insufficiency].
    La Marca G; Pumilia G; Martino A
    Minerva Cardioangiol; 1999 Sep; 47(9):315-9. PubMed ID: 10630070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Use of a minor fibrinolytic drug (mesoglycan) in phlebitis].
    Scondotto G; De Fabritiis A; Guastarobba A; Amato AC; Filippini M
    Minerva Med; 1984 Jul; 75(28-29):1733-8. PubMed ID: 6236381
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Heparan sulfate: efficacy and safety in patients with chronic venous insufficiency].
    Agrati AM; De Bartolo G; Palmieri G
    Minerva Cardioangiol; 1991 Oct; 39(10):395-400. PubMed ID: 1839430
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A placebo-controlled, double-blind study of mesoglycan in the treatment of chronic venous ulcers.
    Arosio E; Ferrari G; Santoro L; Gianese F; Coccheri S;
    Eur J Vasc Endovasc Surg; 2001 Oct; 22(4):365-72. PubMed ID: 11563899
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [A double-blind controlled clinical study on the use of mucopolysaccharides in the treatment of patients with cerebral vasculopathy. Comparison with a placebo].
    Bardin P; Campo R
    Clin Ter; 1987 Jan; 120(2):111-8. PubMed ID: 2972439
    [No Abstract]   [Full Text] [Related]  

  • 15. Mesoglycan in treatment of patients with cerebral ischemia: effects on hemorheologic and hematochemical parameters.
    Vecchio F; Zanchin G; Maggioni F; Santambrogio C; De Zanche L
    Acta Neurol (Napoli); 1993 Dec; 15(6):449-56. PubMed ID: 8160557
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term sequelae of deep venous thrombosis of the legs. Experience with mesoglycan].
    Prandoni P; Cattelan AM; Carta M
    Ann Ital Med Int; 1989; 4(4):378-85. PubMed ID: 2535067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Treatment of intermittent claudication with mesoglycan--a placebo-controlled, double-blind study.
    Nenci GG; Gresele P; Ferrari G; Santoro L; Gianese F;
    Thromb Haemost; 2001 Nov; 86(5):1181-7. PubMed ID: 11816704
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmaco-EEG study on vincamine and on teproside in patients with chronic cerebrovascular disease.
    Martucci N; Manna V; Agnoli A
    Int J Clin Pharmacol Res; 1984; 4(4):291-302. PubMed ID: 6500776
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment with mesoglycan of chronic obliterative atherosclerotic arteriopathies of the legs. Hematochemical and flowmetric changes].
    di Giovanna VN
    Clin Ter; 1988 Jun; 125(6):431-4. PubMed ID: 2973949
    [No Abstract]   [Full Text] [Related]  

  • 20. Regional cerebral saturation versus transcranial Doppler during carotid endarterectomy under regional anaesthesia.
    Pugliese F; Ruberto F; Tosi A; Martelli S; Bruno K; Summonti D; D'Alio A; Diana B; Anile M; Panico A; Speziale F; Pietropaoli P
    Eur J Anaesthesiol; 2009 Aug; 26(8):643-7. PubMed ID: 19494780
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.